SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-24-001743
Filing Date
2024-05-08
Accepted
2024-05-08 16:23:14
Documents
1
Period of Report
2024-05-06

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 8374
  Complete submission text file 0000929638-24-001743.txt   11368
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Reporting) CIK: 0001583977 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 24926553

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address
Chen Bihua (Reporting) CIK: 0001599214 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 24926552

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Reporting) CIK: 0001618442 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 24926551